Evidence map›Paper›PMID 41565973›Full record

ArticleNPJ digital medicine2026

PrysmNet a polyp refining system using salience and multimodal guidance for reproducible cross domain segmentation.

Junbo Xiao, Yi Han, Lei Wang, Ying Li, Xiaotong Wang, Shizhe Li, Jun Yi, Yu Wu, Xiaowei Liu

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junbo XiaoDepartment of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yi HanDepartment of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Lei WangSchool of Computer Science and Engineering, Central South University, Changsha, Hunan, China.
Ying LiDepartment of Infectious Diseases, Xiangya Hospital, Central South University, Hunan Key Laboratory of Viral Hepatitis, Changsha, Hunan, China.
Xiaotong WangDepartment of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Shizhe LiDepartment of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jun YiDepartment of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yu WuTeaching and Research Section of Clinical Nursing, Xiangya Hospital, Central South University, Changsha, Hunan, China. wuyu527@csu.edu.cn.
Xiaowei LiuDepartment of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan, China. liuxw@csu.edu.cn.

Funding

Hunan Provincial Natural Science Foundation of China 2023JJ30947National Research Center of Geriatric Diseases XYYYJSTG-11National Research Center of Geriatric Diseases, 2024 Xiangya Hospital
6 · The paper itself

Abstract

Colorectal cancer prevention benefits from accurate and reproducible polyp segmentation, yet cross-domain generalization and boundary precision remain challenging in real-world deployments. We propose Prysm-Net, a ViT-based framework designed to address these issues through architectural innovation and advanced training guidance. Our model is augmented with a biologically inspired salience module (BSM) that dynamically sharpens boundary-relevant features. To further enhance robustness without increasing inference costs, we introduce two training-only strategies: (i) foundation-model distillation from SAM, which transfers knowledge at the output, boundary, and feature levels, and (ii) multi-modal guidance that injects auxiliary structural and textural cues via gated cross-attention. Extensive experiments on standard in-domain benchmarks and challenging cross-domain datasets demonstrate that Prysm-Net achieves superior segmentation accuracy and robust generalization compared to state-of-the-art methods, all while maintaining a lightweight inference process by disabling auxiliary guidance at test time.

Identifiers

PMID41565973
PMCPMC12902062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.